“…Although some molecular targets have not been assessed in all of these key regions for both classes of drugs, the available data converge to suggest potential mechanisms by which both AAS exposure and ethanol withdrawal (EtOH-w) augment the expression of corticotropin releasing factor (CRF) in key regions of the anxiety circuitry, including the BnST [24,103], the CeA [25,84,85,100–102], and the DRN [102]. AAS and/or alcohol-dependent changes in CRF may, in turn, alter classical neurotransmission mediated by both GABA A Rs [25,84,85] and glutamate (as assessed by vesicular glutamate transporter 2, VGLUT2) [36] and glutamate receptors (GluRs) [56,103–105]. Finally, AAS and alcohol may significantly alter the activity of 5-HT neurons in the DRN [106] through GABAergic afferents to this region [90,107].…”